NCT02127476View on ClinicalTrials.gov

A Study of Single and Multiple Doses of KHK6640 in Subjects With Prodromal or Mild to Moderate Alzheimer's Disease

PHASE1CompletedINTERVENTIONAL
Enrollment

57

Participants

Timeline

Start Date

July 31, 2014

Primary Completion Date

May 31, 2017

Study Completion Date

May 31, 2017

Conditions
Alzheimer's Disease
Interventions
DRUG

KHK6640

Single ascending dose and multiple ascending doses administration

DRUG

Matching Placebo

Single ascending dose and multiple ascending doses administration

Trial Locations (9)

9000

UZ Gent, De Pintelaan 185, Ghent

FI-20520

Clinical Research Services Turku (CRST), Itäinen Pitkäkatu 4B,, Turku

1081 GM

Department of Neurology and Alzheimer Center, VU University Medical Center, Amsterdam

9700 RB

University Medical Centre Groningen (UMCG), Alzheimer Research Centre, Groningen

11 000

Clinical Centre of Serbia, Neurology Clinic, Dr Subotica Starijeg 6 ,, Belgrade

Military Medical Academy, Crnotravska 17,, Belgrade

SE-205 02

Memory Clinic, Malmo Minneskliniken, Memory Research Unit, Hs 33,, Malmo

SE-43141

Sahlgrenska Gothenburg, Minnesmottagningen, Wallinsgatan 6, Mölndal

SE-141 86

Karolinska Stockholm Karolinska University Hospital, Huddinge, Dept. of Geriatrics/Memory Disorders Unit, Stockholm

Sponsors
All Listed Sponsors
collaborator

Kyowa Hakko Kirin Pharma, Inc.

INDUSTRY

lead

Kyowa Kirin Co., Ltd.

INDUSTRY

NCT02127476 - A Study of Single and Multiple Doses of KHK6640 in Subjects With Prodromal or Mild to Moderate Alzheimer's Disease | Biotech Hunter | Biotech Hunter